I agree the NTI merger shouldn't do anything to the price in theory if done right but as a pink sheet it would kill it. If this was on NYSE like PPG that might be a plausible scenario but only if NTI has alot of value to add into HCTI.
Like I said earlier HCTI needs to get to a point where there PU is a major success and they have a solid revenue stream. Only then can an NTI merger work. It's like merging in a new suite of undeveloped drugs with huge potential.
Our P/E would go from 15 or 20 pre merger to 100+ for a number of years as the products are developed. That kind of merger can't work as a pink sheet. This only works on big boards. Thats where shareholders would pay up for future earnings like that.